Compounds, compositions, and methods for synthesis
Patent Information
- Authority / Receiving Office
- JP · JP
- Patent Type
- Patents
- Current Assignee / Owner
- WAVE LIFE SCI LTD
- Filing Date
- 2023-08-31
- Publication Date
- 2026-04-23
Smart Images

Figure 0007850691001172 
Figure 0007850691000001 
Figure 0007850691000002
Abstract
Claims
1. Formulas IV-a, IV-b, IV-c-1, IV-c-2, IV-d, or IV-e: 【Chemistry 1】 A compound having the structure or a salt thereof, wherein the formula is: P L P is, L is -C(R 3 ) (Caution 4 ) - and R 1 and R 2 These, together with the carbon atoms to which they are bonded, form a five- or six-membered monocyclic ring that does not contain heteroatoms and is optionally substituted, or a nine- to fifteen-membered bicyclic or tricyclic ring that does not contain heteroatoms and is optionally substituted. R 3 is -H, -L s -R, halogen, -CN, -NO 2 , -L s -Si(R) 3 , -OR, -SR, or -N(R) 2 and R 4 and R 5 Together with the intervening atoms, these form an optionally substituted four- or five-membered monocyclic ring having only one heteroatom, which is the nitrogen to which R5 is bonded, or an optionally substituted seven- to ten-membered bicyclic ring having only one heteroatom, which is the nitrogen to which R5 is bonded. Each L s They are independently, covalently bonded, or C 1-30 C having an aliphatic group and 1 to 10 heteroatoms 1-30 A divalent, optionally substituted linear or branched group selected from heteroaliphatic groups, wherein one or more methylene units are optionally and independently C 1-6 Alkylene, C 1-6 Alkenylene, -C≡C-, a divalent carbon atom having 1 to 5 heteroatoms. 1 -C 6 Heteroaliphatic group, -C(R') 2 -, -Cy-, -O-, -S-, -S-S-, -N(R')-, -C(O)-, -C(S)-, -C(NR')-, -C(O)N(R')-, -N(R')C(O)N(R')-, -N(R')C(O)O-, -S(O)-, -S(O) 2 -, -S(O) 2 N(R')-, -C(O)S-, -C(O)O-, -P(O)(OR')-, -P(O)(SR')-, -P(O)(R')-, -P(O)(NR')-, -P(S)(OR')-, -P(S)(SR')-, -P(S)(R')-, -P(S)(NR')-, -P(R')-, -P(OR')-, -P(SR')-, -P(NR')-, -P(OR') [B(R') 3 ]-, -OP(O)(OR')O-, -OP(O)(SR')O-, -OP(O)(R')O-, -OP(O)(NR')O-, -OP(OR')O-, -OP(SR')O-, -OP(NR')O-, -OP(R')O-, or -OP(OR') [B(R') 3 Replaced by any substituted group selected from ]O-, one or more carbon atoms are optionally and independently Cy L Replaced by, Each -Cy- is independent of C 3-20 Alicyclic ring, C 6-20 A divalent group that is optionally substituted, selected from an aryl ring, a 5-20 membered heteroaryl ring having 1-10 heteroatoms, and a 3-20 membered heterocyclyl ring having 1-10 heteroatoms. Each Cy L Independently, C 3-20 Alicyclic ring, C 6-20 A tetravalent group that is optionally substituted, selected from an aryl ring, a 5-20 membered heteroaryl ring having 1-10 heteroatoms, and a 3-20 membered heterocyclyl ring having 1-10 heteroatoms. Each R' is independently -R, -C(O)R, -C(O)OR, or -S(O) 2 It is R, L 7 is -O- or -S-, BA is a nucleic acid base that can be optionally substituted, selected from A, T, C, G, U, and their tautomers. Each of R1s, R2s, R3s, R4s, and R5s is independently Rs, Each R s These are independently -H, halogen, -CN, and -N 3 , -NO, -NO 2 , -L s -R', -L s -Si(R) 3 , -L s -OR', -L s -SR', -L s -N(R') 2 , -O-L s -R', -O-L s -Si(R) 3 , -O-L s -OR', -OL-L s -SR', or -OL-L s -N(R') 2 And, t is between 0 and 20. Ring A s This is an optionally substituted monocyclic, bicyclic, or polycyclic ring having 0 to 10 heteroatoms, R 5s is R s And, Each R is independently either -H or C 1-30 Aliphatic carbon atoms containing 1 to 10 heteroatoms 1-30 Heteroliphatic, C 6-30 Ariel, C 6-30 Aryl aliphatic carbon atoms containing 1 to 10 heteroatoms 6-30 An optionally substituted group selected from aryl heteroaliphatic groups, 5-30 membered heteroaryl groups having 1-10 heteroatoms, and 3-30 membered heterocyclil groups having 1-10 heteroatoms, or The two R groups, either independently or separately, come together to form a covalent bond, or Two or more R groups on the same atom may, independently and arbitrarily, combine with the atom to form an optionally substituted 3-30 member monocyclic, bicyclic, or polycyclic ring having 0-10 heteroatoms in addition to the atom, or A compound or a salt thereof, wherein two or more R groups on two or more atoms optionally and independently combine with the intervening atoms to form an optionally substituted 3-30 member monocyclic, bicyclic, or polycyclic ring having 0-10 heteroatoms in addition to the intervening atoms.
2. The aforementioned compound is of formula IV-e: 【Chemistry 2】 The compound according to claim 1, having the structure.
3. R 2s However, it is -OR, and R is arbitrarily substituted C 1-6 A compound according to any one of claims 1 to 2, wherein it is alkyl.
4. R 2s However, -H, -F, -OMe, or -OCH 2 CH 2 The compound according to any one of claims 1 to 2, wherein the compound is OMe.
5. R 4s The compound according to any one of claims 1 to 4, wherein the compound is -H.
6. The aforementioned compound is of formula IV-d: 【Transformation 3】 It has a structure, R 4s and R 2s These combine and are optionally substituted -O-CH 2 The compound according to claim 1, wherein a - is formed and O is bonded to the carbon at position 2. 【Request Item 7】 【Chemistry 4】 but, 【Transformation 5】 The compound according to claim 6.
8. R 5s The compound according to any one of claims 1 to 7, wherein the compound is DMTrO-.
Citation Information
Patent Citations
Oxaazaphosphoridine and composition containing organic material stabilized thereby
JP1987289589A
Chiral control
JP2015528002A
Processes for producing ribonucleotide analogue with high stereoregularity and deoxyribonucleotide analogue
WO2005092909A1